AKCA
Transfer...
 Symbol:



NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Distressed
# of Employee: 100 / Fiscal Year End: 2018-12-31 / Stock Type: —
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential / / $

Akcea Therapeutics Inc is a late stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders.

Competitors | AnnualReport

Competitors List | Key Matrix Details

AKCA |

Finance Highlights

Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##FinanceKeyRatioHighlights}

Key Ratio Trend

{##FinanceKeyRatioTrend}

Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2017-03-25Quarter9,597k0.0541k-60,353k-60,353k28,884,540100.00%-628.90%-628.90%
2017-06-25Quarter14,128k0.0965k-11,944k-11,944k50,593,340100.00%-84.50%-84.50%
2017-09-25Quarter13,449k0.0224k-14,094k-14,094k53,522,615100.00%-104.80%-104.80%
2017-12-25Quarter18,036k0.00.0-23,361k-23,361k66,541,629100.00%-129.50%-129.50%
2018-03-25Quarter17,108k0.00.0-29,627k-29,627k66,616,337100.00%-173.20%-173.20%
2018-06-25Quarter18,321k39,457k0.0-62,046k-62,046k60,832,494-115.40%-338.70%-338.70%
2018-09-25Quarter19,241k8,944k0.0-63,591k-63,591k87,209,88253.50%-330.50%-330.50%
2018-12-25Quarter10,197k2,789k0.0-70,557k-70,557k89,083,14872.60%-691.90%-691.90%
2019-03-25Quarter163,816k2,444k0.027,187k27,187k94,127,94298.50%16.60%16.60%
2019-06-25Quarter26,623k5,783k0.0-37,323k-37,323k92,795,23878.30%-140.20%-140.20%

Income Statement Trend

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2018-03-25Quarter78.26%0.00%-100.00%-50.91%-50.91%130.63%0.00%-72.46%-72.46%
2018-06-25Quarter29.68%0.00%-100.00%419.47%419.47%20.24%-215.40%300.83%300.83%
2018-09-25Quarter43.07%0.00%-100.00%351.19%351.19%62.94%-46.50%215.36%215.36%
2018-12-25Quarter-43.46%0.00%0.00%202.03%202.03%33.88%-27.40%434.29%434.29%
2019-03-25Quarter857.54%0.00%0.00%-191.76%-191.76%41.30%-1.50%-109.58%-109.58%
2019-06-25Quarter45.31%-85.34%0.00%-39.85%-39.85%52.54%-167.85%-58.61%-58.61%


Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2016-12-25Quarter-17,747k10,684k28,431k9,066k28,410k21k-.6243.134
2017-03-25Quarter-74,942k132,981k207,923k131,422k79,500k128,423k-.360.605
2017-06-25Quarter-82,983k124,104k207,087k122,607k69,047k138,040k-.401.563
2017-09-25Quarter197,843k289,349k91,506k287,880k73,457k18,049k2.162.255
2017-12-25Quarter179,633k268,804k89,171k266,845k80,853k8,318k2.014.303
2018-03-25Quarter146,300k252,465k106,165k250,563k98,296k7,869k1.378.392
2018-06-25Quarter290,404k395,005k104,601k388,721k97,211k7,390k2.776.250
2018-09-25Quarter281,411k379,128k97,717k329,348k90,600k7,117k2.880.275
2018-12-25Quarter276,724k365,261k88,537k267,235k80,661k7,876k3.126.302
2019-03-25Quarter388,864k458,717k69,853k350,885k53,110k16,743k5.567.151

Balance Sheet Trend

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2017-12-25Quarter-1,112.19%2,415.95%213.64%2,843.36%184.59%39,509.52%-422.76%-90.33%
2018-03-25Quarter-295.22%89.85%-48.94%90.66%23.64%-93.87%-482.78%-35.21%
2018-06-25Quarter-449.96%218.29%-49.49%217.05%40.79%-94.65%-792.27%-55.60%
2018-09-25Quarter42.24%31.03%6.79%14.40%23.34%-60.57%33.21%7.84%
2018-12-25Quarter54.05%35.88%-0.71%0.15%-0.24%-5.31%55.21%-0.33%
2019-03-25Quarter165.80%81.70%-34.20%40.04%-45.97%112.77%303.99%-61.48%


Cash Flow Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##CashFlowHighlights}

Cash Flow Trend

{##CashFlowTrend}


Finance Detail

Income Statement Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Balance Sheet Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Cash Flow Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top




Note